Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine interaction with rosuvastatin protection against forearm ischemia-reperfusion injury
2007-000151-33Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in myocardial infarction (MI) comparing Rosuvastatin + caffeine with Rosuvastatin + placebo (2 arms). Primary endpoint: Annexin A5 targeting. Started Mar 2007; status: completed.
02
Drugs
rosuvastatincaffeine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2007-000151-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000151-33.